Skip to Main Content

Stephanie Mary Halene, MD, Dr Med

Hematology, Leukemia & Lymphoma
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
No
Referral required
From physicians only
Board Certified in
Hematology (Internal Medicine) and Internal Medicine

Biography

Stephanie Halene, MD, is chief of hematology at Yale Cancer Center and Smilow Cancer Hospital, and says she enjoys the close relationships she forms with patients and the detective work that is often involved in her clinical care and research.

“Hematology has two aspects: malignant disorders, such as leukemia and lymphoma, and what we call benign or classical hematologic disorders,” Dr. Halene says. “Either way, patients can be very sick, and it takes a lot of piecing clues together and working with other specialists to understand what is going on.”

Dr. Halene is a physician-scientist who studies hematopoiesis (formation of new blood cells) and myelopoiesis (production of bone marrow or bone marrow cells) and how RNA modifications contribute to leukemia and myelodysplastic syndromes (conditions caused by blood-forming cells in the bone marrow that become abnormal).

“My research is broad. Whereas some scientists go after a pathway or a certain approach, everything I do comes back to understanding hematopoiesis and that malignant transformation,” she says. “My work is also very collaborative as we can harness our scientific findings to advance our understanding and care of myelodysplastic syndromes.”

Dr. Halene says the field of hematology is ripe for continued advances. “I don’t think the speed of new discoveries has ever been better than it is now. There have been many incredible advances in technology to better understand the mechanisms of disease and several new agents to treat disease,” she says.

She is also director of the DeLuca Center for Innovation in Hematology Research, which has established a comprehensive biospecimen bank and awarded grant funding to advance discoveries in hematologic malignancies and classical hematologic disorders.

Titles

  • Arthur H and Isabel Bunker Professor of Medicine (Hematology) and Professor of Pathology
  • Chief, Section of Hematology
  • Director, DeLuca Center for Innovation in Hematology Research, Yale Cancer Center
  • Assistant Medical Director CRSL, Yale Cancer Center
  • Chief, Translational Hematology

Education & Training

  • Fellow
    Yale University School of Medicine (2006)
  • Resident
    Yale-New Haven Hospital (2002)
  • Postdoctoral Associate
    Childrens Hospital Los Angeles (2000)
  • Dr Med
    Eberhard-Karls-Universitat Tubingen (1997)
  • Resident
    Eberhard-Karls-University (1997)
  • MD
    Eberhard-Karls-Universitat Tubingen (1995)

Languages Spoken

  • English
  • Deutsch (German)
  • Italiano (Italian)

Additional Information

Locations
Yale Cancer Center
Yale New Haven Hospital
20 York Street
New Haven, CT 06510

Biography

Stephanie Halene, MD, is chief of hematology at Yale Cancer Center and Smilow Cancer Hospital, and says she enjoys the close relationships she forms with patients and the detective work that is often involved in her clinical care and research.

“Hematology has two aspects: malignant disorders, such as leukemia and lymphoma, and what we call benign or classical hematologic disorders,” Dr. Halene says. “Either way, patients can be very sick, and it takes a lot of piecing clues together and working with other specialists to understand what is going on.”

Dr. Halene is a physician-scientist who studies hematopoiesis (formation of new blood cells) and myelopoiesis (production of bone marrow or bone marrow cells) and how RNA modifications contribute to leukemia and myelodysplastic syndromes (conditions caused by blood-forming cells in the bone marrow that become abnormal).

“My research is broad. Whereas some scientists go after a pathway or a certain approach, everything I do comes back to understanding hematopoiesis and that malignant transformation,” she says. “My work is also very collaborative as we can harness our scientific findings to advance our understanding and care of myelodysplastic syndromes.”

Dr. Halene says the field of hematology is ripe for continued advances. “I don’t think the speed of new discoveries has ever been better than it is now. There have been many incredible advances in technology to better understand the mechanisms of disease and several new agents to treat disease,” she says.

She is also director of the DeLuca Center for Innovation in Hematology Research, which has established a comprehensive biospecimen bank and awarded grant funding to advance discoveries in hematologic malignancies and classical hematologic disorders.

Titles

  • Arthur H and Isabel Bunker Professor of Medicine (Hematology) and Professor of Pathology
  • Chief, Section of Hematology
  • Director, DeLuca Center for Innovation in Hematology Research, Yale Cancer Center
  • Assistant Medical Director CRSL, Yale Cancer Center
  • Chief, Translational Hematology

Education & Training

  • Fellow
    Yale University School of Medicine (2006)
  • Resident
    Yale-New Haven Hospital (2002)
  • Postdoctoral Associate
    Childrens Hospital Los Angeles (2000)
  • Dr Med
    Eberhard-Karls-Universitat Tubingen (1997)
  • Resident
    Eberhard-Karls-University (1997)
  • MD
    Eberhard-Karls-Universitat Tubingen (1995)

Languages Spoken

  • English
  • Deutsch (German)
  • Italiano (Italian)

Additional Information

Locations
Yale Cancer Center
Yale New Haven Hospital
20 York Street
New Haven, CT 06510
Yale Cancer Center
Yale New Haven Hospital
20 York Street
New Haven, CT 06510